Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.

Measurement of the new anticoagulants.

Harenberg J, Kraemer R.

Thromb Res. 2012 Apr;129 Suppl 1:S106-13. doi: 10.1016/S0049-3848(12)70028-2.

PMID:
22682119
2.

Determination of the anticoagulant effects of new oral anticoagulants: an unmet need.

Harenberg J, Marx S, Erdle S, Krämer R.

Expert Rev Hematol. 2012 Feb;5(1):107-13. doi: 10.1586/ehm.11.79. Review.

PMID:
22272710
3.

Old and new oral anticoagulants for venous thromboembolism and atrial fibrillation: a review of the literature.

Becattini C, Vedovati MC, Agnelli G.

Thromb Res. 2012 Mar;129(3):392-400. doi: 10.1016/j.thromres.2011.12.014. Epub 2012 Jan 20. Review.

PMID:
22264937
4.

New oral anticoagulants for venous thromboembolism: focus on factor Xa and thrombin inhibitors.

Becattini C, Lignani A, Agnelli G.

Curr Drug Discov Technol. 2012 Jun 1;9(2):119-28. Review.

PMID:
21838660
5.
6.

Novel oral anticoagulants: implications in the perioperative setting.

Levy JH, Key NS, Azran MS.

Anesthesiology. 2010 Sep;113(3):726-45. doi: 10.1097/ALN.0b013e3181ebdb15. Review.

PMID:
20700042
7.

Laboratory assessment of the anticoagulant effects of the next generation of oral anticoagulants.

Garcia D, Barrett YC, Ramacciotti E, Weitz JI.

J Thromb Haemost. 2013 Feb;11(2):245-52. doi: 10.1111/jth.12096. Review.

8.

Concept of a point of care test to detect new oral anticoagulants in urine samples.

Harenberg J, Krämer S, Du S, Weiss C, Krämer R.

Thromb J. 2013 Aug 1;11(1):15. doi: 10.1186/1477-9560-11-15.

10.

Factor Xa inhibitors--new anticoagulants for secondary haemostasis.

Perzborn E.

Hamostaseologie. 2009 Aug;29(3):260-7.

PMID:
19644596
11.

New oral anticoagulants in development.

Weitz JI.

Thromb Haemost. 2010 Jan;103(1):62-70. doi: 10.1160/TH09-07-0434. Epub 2009 Oct 26. Review.

PMID:
20062934
12.

Determination of dabigatran in human plasma samples.

Harenberg J, Giese C, Marx S, Krämer R.

Semin Thromb Hemost. 2012 Feb;38(1):16-22. doi: 10.1055/s-0031-1300947. Epub 2012 Feb 7. Review.

PMID:
22314599
13.

Role of new anticoagulants for the prevention of venous thromboembolism after major orthopaedic surgery and in hospitalised acutely ill medical patients.

Ageno W, Spyropoulos AC, Turpie AG.

Thromb Haemost. 2012 Jun;107(6):1027-34. doi: 10.1160/TH11-11-0787. Epub 2012 Mar 22. Review.

PMID:
22437976
14.

Practical use of apixaban in the prevention of venous thromboembolism after total knee or hip replacement.

Lassen MR.

Drugs Today (Barc). 2012 Apr;48(4):249-58. doi: 10.1358/dot.2012.48.4.1738052. Review.

PMID:
22536567
15.

Active online assessment of patients using new oral anticoagulants: bleeding risk, compliance, and coagulation analysis.

Salmela B, Joutsi-Korhonen L, Armstrong E, Lassila R.

Semin Thromb Hemost. 2012 Feb;38(1):23-30. doi: 10.1055/s-0031-1300948. Epub 2012 Feb 7. Review.

PMID:
22314600
16.

New oral anticoagulants.

Galanis T, Thomson L, Palladino M, Merli GJ.

J Thromb Thrombolysis. 2011 Apr;31(3):310-20. doi: 10.1007/s11239-011-0559-8. Review.

PMID:
21327511
17.

Rivaroxaban for the prevention of venous thromboembolism following major orthopedic surgery: the RECORD trials.

Ageno W.

Expert Rev Cardiovasc Ther. 2009 Jun;7(6):569-76. doi: 10.1586/erc.09.37.

PMID:
19505271
18.

[New oral anticoagulants from the perspective of trauma surgery].

Siebenlist S, Haas S, Elser F, Stöckle U.

Unfallchirurg. 2010 Nov;113(11):886-92. doi: 10.1007/s00113-010-1878-5. Review. German.

PMID:
21069505
19.

[New oral anticoagulants. Significance for dermatology and phlebology].

Hahn M, Hach-Wunderle V.

Hautarzt. 2012 Aug;63(8):634-9. doi: 10.1007/s00105-012-2369-0. Review. German. Erratum in: Hautarzt. 2012 Dec;63(12):987.

PMID:
22777269
20.

New oral anticoagulants in atrial fibrillation.

Turpie AG.

Eur Heart J. 2008 Jan;29(2):155-65. Epub 2007 Dec 19. Review.

Items per page

Supplemental Content

Write to the Help Desk